CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia

Authors

  • Esmaeil Allahmoradi Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences,Sari, Iran |2 Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  • Ghasem Janbabaei Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  • Hadi Hossein-Nattaj Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences,Sari, Iran
  • Hossein Asgarian-Omran Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences,Sari, Iran| Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  • Mohsen Tehrani Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences,Sari, Iran
  • Ramin Shekarriz Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  • Saeid Taghiloo Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences,Sari, Iran |2 Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:

Background: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world. This health problem is caused due to the accumulation of mature B-lymphocytes in the peripheral blood and bone marrow. In the course of cancer, CD4+ T cells become “exhausted” and characterized with poor effector functions and the expression of multiple inhibitory receptors. Objective: To investigate the frequency and functional properties of exhausted CD4+ T lymphocytes in patients with CLL. Methods: Peripheral blood mononuclear cells were obtained from 25 untreated CLL patients and 15 healthy volunteers. CLL patients were clinically classified according to the Rai staging system. The frequency of CD4+/Tim-3+/PD-1+ cells was obtained by flow cytometry. To evaluate cell proliferation and cytokine production, CD4+ T cells were isolated and stimulated with phytohemagglutinin and PMA/ionomycin. Concentrations of IL-2, IFN-γ, TNF-α, and IL-10 were measured in the culture supernatants of stimulated cells by the ELISA technique. Results: The percentage of CD4+/Tim-3+/PD-1+ cells was significantly higher in CLL patients than that of healthy controls. CD4+ T cells from CLL patients showed lower proliferative responses, a lower production of IL-2, IFN-γ, and TNF-α, and a higher production of IL-10, compared to healthy controls. CD4+ T cells from CLL patients in advanced clinical stages showed more exhaustion features than those of early stages. Conclusion: Given that the exhaustion phase of T cells can be reversible, targeted blocking of immune inhibitory molecules could be a promising tool to restore the host immune responses against leukemic cells in CLL.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell diffe...

full text

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

While research on T cell exhaustion in context of cancer particularly focuses on CD8+ cytotoxic T cells, the role of inhibitory receptors on CD4+ T-helper cells have remained largely unexplored. TIGIT is a recently identified inhibitory receptor on T cells and natural killer (NK) cells. In this study, we examined TIGIT expression on T cell subsets from CLL patients. While we did not observe any...

full text

Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects

A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy contr...

full text

Extracellular vesicles released by CD40/IL-4 stimulated chronic lymphocytic leukemia cells confer altered functional properties to CD4 T cells

248. Text: 3,879. Blood First Edition Paper, prepublished online April 26, 2016; DOI 10.1182/blood-2015-11-682377 Copyright © 2016 American Society of Hematology For personal use only. on October 4, 2017. by guest www.bloodjournal.org From

full text

Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases

Regulatory T-cells (Tregs) constitute a small subset of cells that are actively involved in maintaining self-tolerance, in immune homeostasis and in antitumor immunity. They are thought to play a significant role in the progression of cancer and are generally increased in patient with chronic lymphocytic leukemia (CLL). Their number correlates with more aggressive disease status and is predicti...

full text

T cells in chronic lymphocytic leukemia: can they fight?

Chronic lymphocytic leukemia (CLL) is a malignancy of mature B cells critically dependent on microenvironmental stimulation for their survival and proliferation. For decades, research focused on the neoplastic B cells, revealing the central role of the B cell receptor (BcR) in CLL pathophysiology and leading to the recent development of drugs that exhibit remarkable clinical efficacy by inhibit...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 14  issue 4

pages  257- 269

publication date 2017-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023